IL17A and psoriasis: In psoriasis, GLP-1RAs have been shown in both basic science models and psoriasis-specific studies to reduce IL-17, attenuate NF-κB signaling, and redistribute invariant natural killer T (iNKT) cells from plaques into circulation [57-59].